SAFETY ANALYSIS OF LONG-TERM ROMIPLOSTIM USE IN PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (ITP)

被引：0

作者：

Rodeghiero, F. ^{[1
]}

Provan, D. ^{[2
]}

Cines, D. ^{[3
]}

Stasi, R. ^{[4
]}

Tarantino, M. ^{[5
]}

Nie, K. ^{[6
]}

Jun, S. ^{[6
]}

机构：

[1] Dept Cell Therapy & Hematol, Vicenza, Italy

[2] Royal London Hosp, Ctr Haematol, London E1 1BB, England

[3] Dept Pathol & Lab Med, Philadelphia, PA USA

[4] St George Hosp, Dept Haematol, London, England

[5] Univ Illinois, Coll Med, Peoria, IL 61656 USA

[6] Amgen Inc, Thousand Oaks, CA 91320 USA

来源：

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0184

引用

页码：73 / 74

页数：2

共 50 条

[31] FINAL SAFETY AND EFFICACY DATA OF LONG-TERM OPEN-LABEL DOSING OF SUBCUTANEOUS (SC) ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)
Tarantino, Michael
Bussel, James
Blanchette, Victor
Beam, Donald
Roy, John
Despotovic, Jenny
Raj, Ashok
Carpenter, Nancy
Mehta, Bhaki
Eisen, Melissa
PEDIATRIC BLOOD & CANCER, 2018, 65
[32] The efficacy and safety of romiplostim in adult patients with chronic immune thrombocytopenia
Cooper, Nichola
Terrinoni, Ilaria
Newland, Adrian
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2012, 3 (05) : 291 - 298
[33] EFFICACY AND SAFETY OF ROMIPLOSTIM VERSUS MEDICAL STANDARD OF CARE AS CHRONIC THERAPY FOR NONSPLENECTOMIZED PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP)
Rummel, J.
Boccia, R.
Macik, B. G.
Pabinger, I.
Selleslag, D.
Gehl, L.
Wang, X.
Berger, D. P.
Kuter, D. J.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 425 - 426
[34] SAFETY AND EFFICACY OF ROMIPLOSTIM IN OVER 200 CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)
Tarantino, Michael
Despotovic, Jenny
Roy, John
Grainger, John
Cooper, Nichola
Beam, Donald
Raj, Ashok
Maschan, Alexey
Kim, June
Eisen, Melissa
PEDIATRIC BLOOD & CANCER, 2019, 66
[35] Long-term outcome following splenectomy for chronic and persistent immune thrombocytopenia (ITP) in adults and childrenSplenectomy in ITP
Rayaz Ahmed
Anup J. Devasia
Auro Viswabandya
Kavitha M. Lakshmi
Aby Abraham
Sampath Karl
John Mathai
Paul M. Jacob
Deepak Abraham
Alok Srivastava
Vikram Mathews
Biju George
Annals of Hematology, 2016, 95 : 1429 - 1434
[36] Efficacy and Safety of Biosimilar Romiplostim Versus Innovator Romiplostim in Patients with Chronic Immune Thrombocytopenia
S. Chandrakala
Manoj Toshniwal
Mitesh Halvawala
Namita Padwal
Neeraj Sidharthan
Pankaj Malhotra
B. Prashantha
Riya Ballikar
Sandip Shah
Shashikant Apte
T. Kasi Viswanathan
Vijay Ramanan
Akhilesh Sharma
Dattatray Pawar
Roshan Pawar
Vinayaka Shahavi
Indian Journal of Hematology and Blood Transfusion, 2023, 39 : 435 - 441
[37] A SINGLE-ARM, OPEN-LABEL, LONG-TERM EFFICACY AND SAFETY STUDY OF SUBCUTANEOUS (SC) ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)
Grainger, John
Bussel, James
Tarantino, Michael
Cooper, Nichola
Beam, Donald
Despotovic, Jenny
Maschan, Alexey
Carpenter, Nancy
Eisen, Melissa
Park, Joseph
PEDIATRIC BLOOD & CANCER, 2018, 65
[38] A Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)
Grainger, John
Bussel, James B.
Cooper, Nichola
Tarantino, Michael
Blanchette, Victor
Despotovic, Jenny
Maschan, Alexey
Carpenter, Nancy
Eisen, Melissa
Mehta, Bhakti
BLOOD, 2016, 128 (22)
[39] A Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)
Grainger, John D.
Bussel, James B.
Tarantino, Michael
Cooper, Nicola
Beam, Donald
Despotovic, Jenny M.
Maschan, Alexey
Carpenter, Nancy
Eisen, Melissa
Park, Joseph
BLOOD, 2017, 130
[40] Long-Term Outcome of Adolescents and Young Adults with Chronic Primary Immune Thrombocytopenia (ITP)
Schifferli, Alexandra
Le Gavrian, Gautier
Aladjidi, Nathalie
Moulis, Guillaume
Godeau, Bertrand
Leblanc, Thierry
Michel, Marc
Leverger, Guy
Fernandes, Helder
Kuehne, Thomas
BLOOD, 2022, 140 : 5551 - 5552

← 1 2 3 4 5 →